MoneyWorks4Me

Cipla reports 4% rise in Q2 consolidated net profit

30 Oct 2025 Evaluate

Cipla has reported result for second quarter ended September 30, 2025 (Q2FY26). 

The company has reported 2.75% rise in its net profit at Rs 1,210.53 crore for the quarter ended September 30, 2025 as compared to Rs 1,178.16 crore for the same quarter in the previous year. The total income of the company increased by 8.22% at Rs 5,480.38 crore for Q2FY26 as compared to Rs 5,064.17 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 3.73% rise in its net profit at Rs 1,351.17 crore for Q2FY26 as compared to Rs 1,302.53 crore for the same quarter in the previous year. The total income of the company increased by 8.52% at Rs 7,858.39 crore for Q2FY26 as compared to Rs 7,241.63 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.45
Dr. Reddys Labs. 1225.00
Cipla 1390.00
Lupin 2071.70
Zydus Lifesciences 1216.10
View more..